The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function

Clinical Pharmacology and Therapeutics

Volumn 63, Issue 5, 1998, Pages 512-518

  Johnson, Heather J ^b   Swan, Suzanne K ^a   Heim Duthoy, Karen L ^b   Nicholls, Andrew J ^b   Tsina, Irene ^b   Tarnowski, Thomas ^b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONIDE; IOHEXOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; GLOMERULUS FILTRATION RATE; HEADACHE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VERTIGO;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; FEMALE; GLOMERULAR FILTRATION RATE; HALF-LIFE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYCOPHENOLIC ACID; PRODRUGS; RENAL DIALYSIS;

EID: 0031836455     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90102-3     Document Type: Article

References (8)

1. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345:1321-5.
2. Sollinger HW, for the US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995;60:225-32.
3. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996;61:1029-37.
4. Bullingham R, Monroe S, Nicholls A, Hale M. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J Clin Pharmacol 1996;36:315-24.
5. Fulton B, Markham A. Mycophenolate mofetil, a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 1996;51:278-98.
6. Brown SCW, O'Reilly PH. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard. J Urol 1991; 146:675-9.
7. Tsina I, Kaloostian M, Lee R, Tarnowski T, Wong B. High-performance liquid chomatographic method for the determination of mycophenolate mofetil in human plasma. J Chromatogr B Biomed Appl 1996;681:347-53.
8. Tsina I, Chu F, Hama K, Kaloostian M, Tam Y, Tarnowski T, et al. Manual and automated (robotic) HPLC methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma. J Chromatogr B Biomed Appl 1996;675:119-29